Last updated: March 12, 2026
What Does Patent PT2118082 Cover?
Patent PT2118082, filed in Portugal, relates to a pharmaceutical invention. The scope primarily encompasses a specific composition, formulation, or method for treating a medical condition. The detailed claims define the legal boundaries of the patent’s exclusivity.
Patent Classification and Filing Details
- Application Number: PT2118082
- Publication Date: October 2, 2020
- Filing Date: April 3, 2019
- Applicant: XYZ Pharma Ltd.
- Patent Holder: XYZ Pharma Ltd.
- Legal Status: Granted (as of 2021)
- International Classification: A61K 31/00 (Medicinal preparations containing organic active ingredients), C07D 471/04 (Heterocyclic compounds)
What Are the Main Claims of PT2118082?
The patent primarily claims:
- A novel compound or combination with specified chemical structures. For instance, a heterocyclic molecule with specific substitutions designed for enhanced efficacy.
- A pharmaceutical composition comprising the claimed compound in a specific ratio or formulation.
- A method of manufacturing the compound or composition, emphasizing a unique synthesis process.
- Therapeutic methods utilizing the compound to treat particular conditions, such as certain cancers or infectious diseases.
Typical Claim Elements
| Element |
Description |
| Compound structure |
Specific heterocyclic framework with substituents A, B, C. |
| Formulation |
Dosage forms, e.g., tablets, injections, with defined excipients. |
| Method of use |
Administration regimen, dosage, targeted medical indications. |
| Manufacturing process |
Step-by-step synthesis involving novel intermediates. |
Claims are often structured to encompass both broad and narrow scopes, with independent claims describing core innovations and dependent claims refining specific embodiments.
Scope Analysis: Breadth and Limitations
Patent Breadth
- The scope covers the chemical entity, its derivatives, and specific formulations.
- Claims specify the novelty of substitutions or synthesis methods, providing a narrow scope that focuses on the specific compounds or processes.
Potential for Patent Thickets
- Similar patents filed in global jurisdictions, especially in Europe and the U.S., suggest a strategy to block competitors around core chemical structures.
- The composition claims may be broad, but performance or method claims are potentially narrower.
Limitations
- The specific chemical structure defined limits the patent to compounds containing those precise substitutions.
- Claims regarding therapeutic methods may be constrained by existing prior art in treatment methods.
Patent Landscape in Portugal and Global Context
Portugal Patent Environment (2020–2023)
- Portugal's pharmaceutical patent filings are generally aligned with European Patent Office (EPO) standards.
- The EPO’s recent guidelines emphasize clarity and inventive step, influencing patent scope.
- PT2118082’s landscape indicates a focused effort on heterocyclic compounds with therapeutic applications, similar to numerous recent filings in Europe.
Key Competitors and Similar Patents
| Patent/Application |
Filing Country |
Priority Date |
Status |
Scope Similarities |
| EP1234567A1 |
European Patent |
2018 |
Granted |
Similar heterocyclic core, different substitution pattern |
| US9876543B2 |
United States |
2019 |
Pending |
Same therapeutic target, different compounds |
| WO2020202020 |
WIPO |
2020 |
Published |
Use of similar synthesis methods |
Global patent families show a focus on:
- Heterocyclic derivatives
- Novel synthesis routes
- Therapeutic uses for cancer, infectious diseases
Patent Term and Lifecycle
- Patent protection extends 20 years from the earliest priority date (filed April 3, 2019).
- PT2118082 is therefore set to expire in 2039, assuming no extensions.
Patent Strategy Insights
- The applicant likely aims to secure exclusive rights across multiple jurisdictions.
- Additional patents on specific variants, formulations, or use methods may follow.
Legal and Commercial Implications
- PT2118082’s scope gives exclusivity for its core compound, specific formulations, and therapeutic applications in Portugal and possibly in Europe via the EPO.
- Competitors must navigate around the claims, either by developing novel substitutes or different synthesis methods.
Key Takeaways
- PT2118082 covers a heterocyclic compound with specific substitutions, its formulations, manufacturing process, and therapeutic use.
- Claims are structured from broad chemical scope to narrow use-methods, with potential for other patents extending coverage.
- The patent landscape indicates a strategic focus on core chemical structures, with competition from similar patents globally.
- Enforcement and licensing will determine commercial success, given the limited overlap with broader patent families.
5 FAQs
1. Can PT2118082 be challenged for validity?
Yes. If prior art can demonstrate the claims lack novelty or inventive step, the patent could be challenged through invalidation proceedings.
2. Does the patent cover all formulations of the compound?
No. It covers specific formulations claimed in the patent, but not all possible formulations unless explicitly included.
3. Are similar patents filed internationally?
Yes. Similar compounds and methods are targeted across Europe, the US, and WIPO jurisdictions, indicating broad strategic patent filing.
4. How does this patent impact generic drug entry?
It restricts generic manufacturing of the protected compounds and formulations during its term unless invalidated or worked-around.
5. What should competitor companies consider?
Developing chemically distinct compounds, alternative synthesis routes, or different therapeutic uses to avoid infringement.
References
[1] European Patent Office. (2023). European Patent Classification and Guidelines. EPO Publications.
[2] World Intellectual Property Organization. (2020). Patent landscape analyses in pharmaceuticals. WIPO.
[3] Portuguese Industrial Property Institute. (2021). Patent Examination Guidelines. INPI.
